Latest Diabetes: Type II news
ACP: Switching From Dulaglutide to Tirzepatide Improves HbA1c Reduction in T2DM
posted April 4th
by modernClinician Editorial Team
by modernClinician Editorial Team
ACC: Semaglutide Beneficial in Patients With T2DM and Peripheral Artery Disease
posted April 2nd
by modernClinician Editorial Team
by modernClinician Editorial Team
Minimal TV Viewing May Cut ASCVD Risk in Those With T2DM Genetic Risk
posted March 12th
by modernClinician Editorial Team
by modernClinician Editorial Team
Risk for Specific Hematologic Cancers Down With GLP-1 Receptor Agonist Use in T2DM
posted March 10th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Very Low-Carb Diet Shows Greater Cardiometabolic Benefits Than Other Diets .jpg)
Time-Restricted Eating May Help Patients With Type 1 Diabetes 
Long-Term Medication Adherence Tied to Lower Cardiovascular Event Rate in Type 2 Diabetes 
Type 2 Diabetes Linked to Worse Menopausal Symptoms Related Articles
Add-On Tirzepatide May Reduce MACE Risk in People With T2D, ASCVD .jpg)
Semaglutide Not Linked to Higher Neovascular Age-Related Macular Degeneration Risk 
AHA: Consuming Up to 400 mg/Day of Caffeine Safe for Most Adults 
GLP-1 Receptor Agonist Use Linked to Higher Risk for Ischemic Optic Neuropathy Monthly Specialist Briefings
Stay Connected
